Most breast tumors express ERα, and stimulation of ERα by estradiol plays a significant role in breast tumor progression ERα-targeted therapies including tamoxifen demonstrate exceptional clinical efficacy in treating breast cancer [42]. Here, ESR1 is linked to breast carcinoma.